A Study of Guselkumab in Participants With Active Lupus Nephritis
Clinical trial NCT04376827 · TERMINATED
Trial details
- NCT number
- NCT04376827
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2023-02-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.